SEC Filing Summary: SkinHealth Systems Inc. (SKIN)
Business Context and Reporting Period
This Form 8-K, dated August 6, 2026, serves as a current report for SkinHealth Systems Inc., a Delaware corporation trading on the Nasdaq Capital Market. The filing announces the release of financial results for the fiscal quarter ended June 30, 2026. The company directs investors to a press release (Exhibit 99.1) and a conference call for detailed operational data.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not embedded in the body of this 8-K form. The company notes the use of non-GAAP financial information in its disclosures, with a reconciliation to GAAP results provided in the exhibit.
Material Changes
No specific material changes versus the prior comparable period are detailed in this filing. The document functions solely as a notification of the results release rather than a comparative analysis.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or management commentary beyond the announcement of the results release. It includes a standard disclosure regarding the company's communication channels, stating that material information is disseminated via SEC filings, press releases, conference calls, and the investor relations website to comply with Regulation FD. No specific risks or contingencies are outlined in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the quarter ended June 30, 2026.
- Examine the reconciliation of GAAP to non-GAAP financial metrics provided in the press release.
- Verify the company's liquidity position and debt levels in the full financial statements referenced in the exhibit.
- Confirm any forward-looking statements or guidance issued during the associated conference call.